Sept. 14 (UPI) --A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical tests, drugmaker Pfizer announced Saturday. The experimental ...
Effect of distress on total toxicity burden and activities of daily living among 382 advanced stage cancer patients: A URCC CCOP research base study. This is an ASCO Meeting Abstract from the 2014 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback